(19)
(11) EP 4 493 586 A1

(12)

(43) Date of publication:
22.01.2025 Bulletin 2025/04

(21) Application number: 23710899.8

(22) Date of filing: 15.03.2023
(51) International Patent Classification (IPC): 
C07K 16/10(2006.01)
 A61K 39/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/10; C07K 2317/76; C07K 2317/34; C07K 2317/92; A61K 2039/505
(86) International application number:
PCT/EP2023/056552
(87) International publication number:
WO 2023/174976 (21.09.2023 Gazette 2023/38)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 16.03.2022 EP 22162453

(71) Applicants:
  • Universität zu Lübeck
    23562 Lübeck (DE)
  • Twincore, Zentrum für Experimentelle und Klinische Infektionsforschung GmbH
    30625 Hannover (DE)

(72) Inventors:
  • KREY, Thomas
    23627 Groß Sarau (DE)
  • SSEBYATIKA, George
    23564 Lübeck (DE)
  • DINKELBORG, Katja
    Hannover 30655 (DE)
  • BEHRENDT, Patrick
    30938 Burgwedel (DE)

(74) Representative: Moré, Solveig Helga et al
Kroher Strobel Rechts- und Patentanwälte PartmbB Bavariaring 20
80336 München
80336 München (DE)

   


(54) BROADLY NEUTRALIZING ANTIBODIES AGAINST HEPATITIS E VIRUS